Detalhe da pesquisa
1.
Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies.
Cancer Immunol Immunother
; 72(12): 4031-4047, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37814001
2.
Sex Differences in Tolerability to Anti-Programmed Cell Death Protein 1 Therapy in Patients with Metastatic Melanoma and Non-Small Cell Lung Cancer: Are We All Equal?
Oncologist
; 24(11): e1148-e1155, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036771
3.
Biomarkers of hyperprogression and pseudoprogression with immune checkpoint inhibitor therapy.
Future Oncol
; 15(22): 2645-2656, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298573
4.
Case series of dabrafenib-trametinib-induced pyrexia successfully treated with colchicine.
Support Care Cancer
; 27(10): 3869-3875, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30767130
5.
NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
Cancer
; 124(3): 537-545, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29044496
6.
Whole Blood mRNA Expression-Based Prognosis of Metastatic Renal Cell Carcinoma.
Int J Mol Sci
; 18(11)2017 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29099775
7.
Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors - a major reason for enhanced chemosensitivity?
Chin J Cancer Res
; 29(4): 374-378, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28947870
8.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
N Engl J Med
; 369(2): 134-44, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23724846
9.
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
JAMA
; 315(15): 1600-9, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092830
10.
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Lancet
; 384(9948): 1109-17, 2014 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25034862
11.
Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.
BJU Int
; 113(5b): E17-21, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24006893
12.
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Prostate Cancer Prostatic Dis
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341460
13.
Neoadjuvant cobimetinib and atezolizumab with or without vemurafenib for high-risk operable Stage III melanoma: the Phase II NeoACTIVATE trial.
Nat Commun
; 15(1): 1430, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365756
14.
Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
BJU Int
; 111(7): 1046-53, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23551810
15.
Patient- and Provider-Level Factors Associated With Telehealth Utilization Across a Multisite, Multiregional Cancer Practice From 2019 to 2021.
JCO Oncol Pract
; 19(9): 750-758, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37335959
16.
Universal Genetic Testing vs. Guideline-Directed Testing for Hereditary Cancer Syndromes Among Traditionally Underrepresented Patients in a Community Oncology Program.
Cureus
; 15(4): e37428, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37181954
17.
Post-Autologous Hematopoietic Cell Transplant Care in the "Home Sweet Home" Setting: A Treatment Paradigm Shift.
Hematol Oncol Stem Cell Ther
; 16(4): 407-411, 2023 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37363981
18.
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Front Immunol
; 14: 1279387, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38022659
19.
Personalized therapy for metastatic melanoma: could timing be everything?
Future Oncol
; 8(11): 1401-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23148614
20.
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
Cancer Immunol Res
; 10(2): 162-181, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911739